Study shines light on hidden struggles of advanced ovarian cancer families

NCT ID NCT07035067

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: PeriPharm Source: ClinicalTrials.gov ↗

Summary

This study aims to understand the full impact of advanced, treatment-resistant ovarian cancer on patients and their caregivers in Canada. Researchers will survey 150 patients and their caregivers about their quality of life, symptoms, work challenges, and treatment preferences. The goal is to identify the real-world hurdles they face to highlight areas of unmet need.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • PROxy Network, an initiative of PeriPharm Inc.

    Montreal, Quebec, H2Y 1V3, Canada

Conditions

Explore the condition pages connected to this study.